GeneralConnection.com ➔ Dictionary
Dictionary Search

hemophilia b

Synonyms

Noun

1. hemophilia B

2. haemophilia B, Christmas disease, hemophilia, haemophilia, bleeder's disease

Usage
Prophylaxis vs. On-Demand Treatment for Hemophilia B - HealthCentral
Hemophilia B Treatment: Options and Advances - HealthCentral
Be Bio bins hemophilia B cell therapy trial—the biotech’s lead program - BioSpace
Hemophilia B: FDA reopens the path for etranacogene dezaparvovec after prior uncertainty - Vera Health
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
Marstacimab sBLA for Expanded Use in Hemophilia A or B Gets Priority Review - Hematology Advisor
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials - Nature
Explainer: Why Is Hemophilia B Called Christmas Disease? - Global Biotechnology Company
4 Things to Expect for the Future of Hemophilia Treatment - Docwire News
China’s first hemophilia B gene therapy now approved in Macao - Hemophilia News Today
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Universal hope for hemophilia - The University of North Carolina at Chapel Hill
FDA Expands Marstacimab Indication in Hemophilia A and B - Conexiant
New treatment for Hemophilia B brings hope to patients - FOX 2 Detroit
9 Myths and Facts About Hemophilia B - HealthCentral
Single-Dose Gene Therapy Shows Promising Safety, Efficacy, and Patient-Reported Outcomes in Hemophilia B - Docwire News
New data suggest gene therapy may reach more hemophilia B patients - Hemophilia News Today
Hemophilia B: Symptoms, Causes, and Treatment Options - HealthCentral
New gene therapy reduces bleeding rates for hemophilia B patients - Hemophilia News Today
The potential of bringing hemophilia B gene therapy to younger patients - CGTLive®
CSL Canada Announces First Canadian Patient Receives HEMGENIX® (etranacogene dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada - Yahoo Finance
Optimization of hemophilia B treatment via population PK modeling of rIX-FP, including a 3-week regimen - Frontiers
Hemophilia B drug Idelvion is now available at KHF-run clinics - koreabiomed.com
Gene therapy Beqvez sustains gains in 6-year hemophilia B study - Hemophilia News Today
Steven W. Pipe, MD, on Integrating Gene Therapy into Clinical Care for Hemophilia B - CGTLive®
Utah Center for Bleeding & Clotting Disorders at University of Utah Health Administers New Gene Therapy for Hemophilia B - School of Medicine | University of Utah
Single-infusion etranacogene dezaparvovec in men with hemophilia B (factor IX activity ≤2 IU/dL) was associated with sustained factor IX expression and reduced annualized bleeding rates through 5 years - Vera Health
Hemophilia B Gene Therapy Continues to Reduce Bleeding - Medscape
How durable is gene therapy for haemophilia B? - Nature
Patients With Hemophilia B Report Improvement in QoL After Gene Therapy - Hematology Advisor
Gene therapy can help reduce joint bleeds in hemophilia B: New data - Hemophilia News Today
Five-year results highlight new treatment option for hemophilia B - Hemophilia News Today
Longer Follow-Up Data Reinforce Concizumab’s Efficacy in Hemophilia A and B With Inhibitors - Docwire News
FDA expands marstacimab (HYMPAVZI) approval to children ages 6–11 and hemophilia patients with inhibitors - Contemporary Pediatrics
Karmanos Cancer Institute Becomes First and Only Free-Standing Cancer Center to Treat Hemophilia B with New Gene Therapy - McLaren Health
B cell therapy maker Be Bio stops hemophilia trial - Endpoints News
Distribution of people with hemophilia B in the U.S. in 2024, by age group - Statista
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors - Business Wire
Marstacimab-hncq (Hympavzi) Gains FDA Approval for Expanded Hemophilia A and B Indication in Patients Aged 6 Years and Older - Consultant360
No Elevated Risk for Renal Dysfunction Seen in Hemophilia B Patients Without Inhibitors - Hematology Advisor
FDA may OK Hympavzi for children 6 and older with hemophilia A or B - Hemophilia News Today
Advances in hemophilia, sickle cell disease, and thalassemia - Penn Medicine
Hemophilia Studies Today: Points of Interest - Docwire News
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
New FIX versions may be used to create hemophilia B treatments - Hemophilia News Today
FX activator may help with bleeding control in hemophilia A and B: Trials - Hemophilia News Today
FDA grants priority review to marstacimab (Hympavzi) for younger children and patients with hemophilia inhibitors - Contemporary Pediatrics
ASH: CSL proves efficacy of hemophilia B gene therapy Hemgenix holds up after 5 years - Fierce Pharma
Gene therapy comes of age to staunch hemophilia B - St. Jude Children's Research Hospital
(marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Gene Therapy Supply Runs Out, Company Warns of Treatment Delays - MedPage Today
HOPE-B: 5-Year Etranacogene Dezaparvovec Maintains Durable Efficacy and Safety in Hemophilia B, With Steven Pipe, MD - HCPLive
Hemophilia B gene therapy Hemgenix to be covered in Canada - Hemophilia News Today
Sanofi’s hemophilia B therapy Alprolix approved for 6-month room-temperature storage - koreabiomed.com
HOPE-B Shows Bleeding Control Still Holding at 5 Years - Docwire News
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
Advances in hemophilia gene therapy bring hope for pediatric patients - News-Medical
AAV Gene Therapy in Severe Hemophilia B - The New England Journal of Medicine
Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial - CGTLive®
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
End-of-Study Results From Hemgenix’s HOPE-B Trial - CGTLive®
CSL warns of supply shortfall, treatment delays for hemophilia gene therapy Hemgenix - Fierce Pharma
In Hemophilia B, One-Stage Assay After Gene Therapy Recommended - Hematology Advisor
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
EAHAD 2026: Nine-Year Outcomes of Gene Therapy - EMJ
HHS pharmacy sets national benchmark: First-ever delivery of groundbreaking $4.5M Hemophilia B treatment - Hospital News
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
Alhemo Indication Expanded to Include Hemophilia A/B Without Inhibitors - Hematology Advisor
CSL says hemophilia B gene therapy is temporarily out of stock, warns of treatment delays - Endpoints News
Hemophilia gene therapies are struggling on the market, even as innovation soars - Pharma Voice
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties - Nature
Data on ABRs in Severe Pediatric Hemophilia Key to Benchmarking Prophylaxis - Hematology Advisor
CSL Canada Announces First Canadian Patient Receives HEMGENIX® (etranacogene dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada – Company Announcement - FT.com - Financial Times
Evolving treatment paradigms in hemophilia: A written recap - Managed Healthcare Executive
Concizumab-mtci Approved to Treat Hemophilia A/B Without Inhibitors - Hematology Advisor
Children's Hospital of Philadelphia played key role in developing new treatment for hemophilia - CBS News
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors - PR Newswire
First Patient Dosed in Clinical Trial of An Engineered B-Cell Medicine for Hemophilia B - Docwire News
How Gene Therapy Is Transforming Hemophilia B Treatment - Docwire News
FDA Approves Extended Indication for Concizumab-Mtci for Hemophilia A and B - Docwire News
BioMarin, following sluggish sales, to offload hemophilia gene therapy - BioPharma Dive
Speaking with the man, first in Canada, to receive breakthrough hemophilia B gene therapy - CTV News
China Explores Weight-Based Pricing for First Domestic Hemophilia B Gene Therapy - NAVLIN DAILY
Hemophilia B gene therapy demonstrates long-term success - St. Jude Children's Research Hospital
How to Plan for Emergencies When You Have Hemophilia B - Everyday Health
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
Therapy now available for patients with Hemophilia B - CP24
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study - The New England Journal of Medicine
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B - The New England Journal of Medicine
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B - The New England Journal of Medicine
First subject dosed in Be Biopharma’s trial of haemophilia B therapy - Clinical Trials Arena
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B - The New England Journal of Medicine
European Medicines Agency Issues Positive Opinion for Concizumab Label Update in Hemophilia - Docwire News
With hemophilia B, a lifetime of worry eased with one infusion - Penn Today
How Fitusiran Changes the Treatment Landscape in Hemophilia: Guy Young, MD - AJMC
UC San Diego Health First to Offer Novel Gene Therapy for Hemophilia B - UC San Diego Health
Encouraging Phase 3 Data Released: Marstacimab for Hemophilia A or B With Inhibitors - Docwire News
U.S. Food and Drug Administration approves CSL’s HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia B - BioMelbourne Network
Single-dose gene therapy is potentially life-changing for adults with hemophilia B - Penn Medicine
AAV gene therapy shows durable benefit in hemophilia B - 2 Minute Medicine
Foreign Language Equivalents
Foreign Language Equivalents of 'hemophilia b'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
hemophiilia b,   hemophilia b,   gemophilia b,   hemophili b,   hemoohilia b,   hemophikia b,   hwmophilia b,   hemophilai b,   hemophilia n,   jemophilia b,   hemopgilia b,   hmophilia b,   hemophliia b,   hemophi;ia b,   hemophiloa b,   hempohilia b,   hemohilia b,   hemophila b,   hemopihlia b,   hemophiliab ,   hempphilia b,   hemophulia b,   hemophlia b,   hhemophilia b,   hemohpilia b,   hemophiila b,   hemophillia b,   hemo[hilia b,   hrmophilia b,   hemophilia ,   hemophhilia b,   hemophiliab,   hemopilia b,   henophilia b,   hemophiia b,   hemophilis b,   hemopholia b,   hmeophilia b,   hemophili ab,   hemopjilia b,   he,ophilia b,   hemopphilia b,   hemophilia v,   hemmophilia b,   hemoophilia b,   hemphilia b,   hemophilua b,   hemophiliaa b,   hemiphilia b,   heomphilia b,   ehmophilia b,   hemophiliia b,   emophilia b,   heemophilia b,   heophilia b,   hemophilia bb
Words Starting with Letter - 'G'
glass glass ceiling glass cutter
glass eye glass fiber glass fibre
glass in glass lizard glass over
glass snake glass sponge glass wool
glass-cutter glassblower glassed
glasses glasses case glassful
glasshouse glassless glassmaker
glassware glasswork glassworker
« Go to Page 238            Go to Page 240 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z